ArticleScientific reports2025
Periodontopathogens degrade angiotensin I from the human renin-angiotensin system through surface-attached proteases.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The renin-angiotensin system (RAS) has its effects through biologically-active peptides, the angiotensins (Ang). The angiotensinogen-derived precursor, Ang I, is cleaved either to proinflammatory Ang II, which increases blood pressure or to Ang 1-7, which has opposite effects to Ang II. Here, we show that Porphyromonas gingivalis (Pg) and Tannerella forsythia (Tf), endogenous oral pathogens, direct the RAS to generate Ang 1-7 through the actions of the endopeptidases O PgPepO and TfPepO, respectively. The thermophilic PepOs metalloproteases preferred large hydrophobic amino acids at the carbonyl terminus of scissile peptide bonds (P1' position), and TfPepO, in contrast to all known homologous proteases, hydrolyzed substrates distant to both termini. The crystal structures revealed exceptionally wide entrances to the catalytic cleft, which explains the unique properties of TfPepO. Multiple immunoassays showed that PepOs attached to bacterial cell surfaces are released in outer membrane vesicles. Moreover, PepO was responsible for Ang I hydrolysis by Pg and Tf. Finally, PepO deletion reduced only the virulence of Tf using the Galleria mellonella model. Thus, our data show that PepOs are the only proteases of Pg and Tf, which may modulate RAS through AngI hydrolysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.